Johannes Czernin, MD
Dr. Johannes Czernin is a Professor of Molecular and Medical Pharmacology at the David Geffen School of Medicine at UCLA. He received his MD degree from the University of Vienna in 1983 and was board certified in Internal Medicine in Austria in 1989 and in Nuclear Medicine in 1996 in the USA. He was named Director of Nuclear Medicine at the David Geffen School of Medicine at UCLA in 1996 and currently serves as the Chief of the Ahmanson Translational Theranostics Division at UCLA. The Division includes the Nuclear Medicine Clinic, a clinical imaging research program, a drug and probe development program with a strong underpinning in tumor biology, a preclinical imaging and biomedical radiochemistry center. His group successfully applied to the FDA for an NDA for a PSMA targeted PET imaging probe in prostate cancer. The Division collaborates within the department of molecular and medical pharmacology and across several other departments including urology, radiation oncology, oncology, surgery, radiology, neurology, pathology and others to advance preclinical and clinical theranostics.
Dr. Czernin is currently Editor-in- Chief of the Journal of Nuclear Medicine and is a past president of the Academy of Molecular Imaging. He has published more than 280 peer-reviewed research papers.